131 related articles for article (PubMed ID: 29908121)
21. The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease.
Levade T; Tempesta MC; Salvayre R
FEBS Lett; 1993 Aug; 329(3):306-12. PubMed ID: 8365472
[TBL] [Abstract][Full Text] [Related]
22. Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency.
Nagree MS; Rybova J; Kleynerman A; Ahrenhoerster CJ; Saville JT; Xu T; Bachochin M; McKillop WM; Lawlor MW; Pshezhetsky AV; Isaeva O; Budde MD; Fuller M; Medin JA
Commun Biol; 2023 May; 6(1):560. PubMed ID: 37231125
[TBL] [Abstract][Full Text] [Related]
23. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
[TBL] [Abstract][Full Text] [Related]
24. Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.
Sikora J; Dworski S; Jones EE; Kamani MA; Micsenyi MC; Sawada T; Le Faouder P; Bertrand-Michel J; Dupuy A; Dunn CK; Xuan ICY; Casas J; Fabrias G; Hampson DR; Levade T; Drake RR; Medin JA; Walkley SU
Am J Pathol; 2017 Apr; 187(4):864-883. PubMed ID: 28342444
[TBL] [Abstract][Full Text] [Related]
25. Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.
Yu FPS; Islam D; Sikora J; Dworski S; Gurka J; López-Vásquez L; Liu M; Kuebler WM; Levade T; Zhang H; Medin JA
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L406-L420. PubMed ID: 29167126
[TBL] [Abstract][Full Text] [Related]
26. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system.
Chedrawi AK; Al-Hassnan ZN; Al-Muhaizea M; Colak D; Al-Younes B; Albakheet A; Tulba S; Kaya N
Brain Dev; 2012 May; 34(5):400-4. PubMed ID: 21893389
[TBL] [Abstract][Full Text] [Related]
27. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.
Norris MK; Tippetts TS; Wilkerson JL; Nicholson RJ; Maschek JA; Levade T; Medin JA; Summers SA; Holland WL
Mol Genet Metab Rep; 2024 Jun; 39():101077. PubMed ID: 38595987
[TBL] [Abstract][Full Text] [Related]
29. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
[TBL] [Abstract][Full Text] [Related]
30. Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology.
Sands MS
EMBO Mol Med; 2013 Jun; 5(6):799-801. PubMed ID: 23666771
[No Abstract] [Full Text] [Related]
31. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.
Li CM; Park JH; Simonaro CM; He X; Gordon RE; Friedman AH; Ehleiter D; Paris F; Manova K; Hepbildikler S; Fuks Z; Sandhoff K; Kolesnick R; Schuchman EH
Genomics; 2002 Feb; 79(2):218-24. PubMed ID: 11829492
[TBL] [Abstract][Full Text] [Related]
32. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
[TBL] [Abstract][Full Text] [Related]
33. Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease.
Farina F; Cappello F; Todaro M; Bucchieri F; Peri G; Zummo G; Stassi G
J Histochem Cytochem; 2000 Jan; 48(1):57-62. PubMed ID: 10653586
[TBL] [Abstract][Full Text] [Related]
34. [Farber's lipogranulomatosis].
Koga M
Nihon Rinsho; 1995 Dec; 53(12):3009-13. PubMed ID: 8577050
[TBL] [Abstract][Full Text] [Related]
35. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
36. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation.
Bashyam MD; Chaudhary AK; Kiran M; Reddy V; Nagarajaram HA; Dalal A; Bashyam L; Suri D; Gupta A; Gupta N; Kabra M; Puri RD; RamaDevi R; Kapoor S; Danda S
Clin Genet; 2014 Dec; 86(6):530-8. PubMed ID: 24355074
[TBL] [Abstract][Full Text] [Related]
37. A simple method for screening for Farber disease on cultured skin fibroblasts.
Chatelut M; Feunteun J; Harzer K; Fensom AH; Basile JP; Salvayre R; Levade T
Clin Chim Acta; 1996 Feb; 245(1):61-71. PubMed ID: 8646815
[TBL] [Abstract][Full Text] [Related]
38. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging.
Jones EE; Dworski S; Canals D; Casas J; Fabrias G; Schoenling D; Levade T; Denlinger C; Hannun YA; Medin JA; Drake RR
Anal Chem; 2014 Aug; 86(16):8303-11. PubMed ID: 25072097
[TBL] [Abstract][Full Text] [Related]
39. A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.
He X; Li CM; Park JH; Dagan A; Gatt S; Schuchman EH
Anal Biochem; 1999 Oct; 274(2):264-9. PubMed ID: 10527524
[TBL] [Abstract][Full Text] [Related]
40. Farber disease in a patient from China.
Bao X; Ma M; Zhang Z; Xu Y; Qiu Z
Am J Med Genet A; 2020 Sep; 182(9):2184-2186. PubMed ID: 32706452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
